Tecalco-Cruz A, Rios-Lopez D, Vazquez-Victorio G, Rosales-Alvarez R, Macias-Silva M
Signal Transduct Target Ther. 2018; 3:15.
PMID: 29892481
PMC: 5992185.
DOI: 10.1038/s41392-018-0015-8.
Singbrant S, Wall M, Moody J, Karlsson G, Chalk A, Liddicoat B
Haematologica. 2014; 99(4):647-55.
PMID: 24415629
PMC: 3971074.
DOI: 10.3324/haematol.2013.093971.
Ding B, Sun Y, Huang J
J Biol Chem. 2012; 287(18):14621-30.
PMID: 22411991
PMC: 3340287.
DOI: 10.1074/jbc.M111.301523.
Lin Q, Chen D, Timchenko N, Medrano E
Cell Cycle. 2010; 9(9):1684-9.
PMID: 20404506
PMC: 3235508.
DOI: 10.4161/cc.9.9.11292.
Zhang H, Stavnezer E
J Biol Chem. 2008; 284(5):2867-2879.
PMID: 19008232
PMC: 2631951.
DOI: 10.1074/jbc.M807526200.
Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski.
Takeda M, Mizuide M, Oka M, Watabe T, Inoue H, Suzuki H
Mol Biol Cell. 2003; 15(3):963-72.
PMID: 14699069
PMC: 363053.
DOI: 10.1091/mbc.e03-07-0478.
Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor.
Nomura T, Khan M, Kaul S, Dong H, Wadhwa R, Colmenares C
Genes Dev. 1999; 13(4):412-23.
PMID: 10049357
PMC: 316468.
DOI: 10.1101/gad.13.4.412.
An essential role of phosphatidylinositol 3-kinase in myogenic differentiation.
Jiang B, Zheng J, Vogt P
Proc Natl Acad Sci U S A. 1998; 95(24):14179-83.
PMID: 9826674
PMC: 24347.
DOI: 10.1073/pnas.95.24.14179.
DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI.
Tarapore P, Richmond C, Zheng G, Cohen S, Kelder B, Kopchick J
Nucleic Acids Res. 1997; 25(19):3895-903.
PMID: 9380514
PMC: 146989.
DOI: 10.1093/nar/25.19.3895.
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
Berk M, Desai S, Heyman H, Colmenares C
Genes Dev. 1997; 11(16):2029-39.
PMID: 9284043
PMC: 316447.
DOI: 10.1101/gad.11.16.2029.
Proto-oncogene Sno expression, alternative isoforms and immediate early serum response.
Pearson-White S, Crittenden R
Nucleic Acids Res. 1997; 25(14):2930-7.
PMID: 9207045
PMC: 146803.
DOI: 10.1093/nar/25.14.2930.
SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno.
Pearson-White S
Nucleic Acids Res. 1993; 21(19):4632-8.
PMID: 8233802
PMC: 311202.
DOI: 10.1093/nar/21.19.4632.
Activation of a muscle-specific enhancer by the Ski proto-oncogene.
Engert J, Servaes S, Sutrave P, Hughes S, Rosenthal N
Nucleic Acids Res. 1995; 23(15):2988-94.
PMID: 7659522
PMC: 307140.
DOI: 10.1093/nar/23.15.2988.
Activation of the c-ski oncogene by overexpression.
Colmenares C, Sutrave P, Hughes S, Stavnezer E
J Virol. 1991; 65(9):4929-35.
PMID: 1870207
PMC: 248954.
DOI: 10.1128/JVI.65.9.4929-4935.1991.
Characterisation of a genomic clone covering the structural mouse MyoD1 gene and its promoter region.
Zingg J, Alva G, Jost J
Nucleic Acids Res. 1991; 19(23):6433-9.
PMID: 1754380
PMC: 329190.
DOI: 10.1093/nar/19.23.6433.
C-ski cDNAs are encoded by eight exons, six of which are closely linked within the chicken genome.
Grimes H, Szente B, Goodenow M
Nucleic Acids Res. 1992; 20(7):1511-6.
PMID: 1579443
PMC: 312231.
DOI: 10.1093/nar/20.7.1511.
Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor.
Funk W, Wright W
Proc Natl Acad Sci U S A. 1992; 89(20):9484-8.
PMID: 1329097
PMC: 50156.
DOI: 10.1073/pnas.89.20.9484.